The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer

Journal of Gynecologic Oncology

Volumn 25, Issue 2, 2014, Pages 90-96

  Kuji, Shiho ^a   Hirashima, Yasuyuki ^a   Komeda, Satomi ^a   Tanaka, Aki ^a   Abe, Masakazu ^a   Takahashi, Nobutaka ^a   Takekuma, Munetaka ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Peritoneal cytology; Prognosis; Radical hysterectomy; Uterine cervical cancer

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; DISEASES; DISSECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PELVIS LYMPH NODE; RADICAL HYSTERECTOMY; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VAGINA;

EID: 84899151935     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2014.25.2.90     Document Type: Article

References (10)

1. Takeshima N, Katase K, Hirai Y, Yamawaki T, Yamauchi K, Hasumi K. Prognostic value of peritoneal cytology in patients with carcinoma of the uterine cervix. Gynecol Oncol 1997; 64: 136-40.
2. Kasamatsu T, Onda T, Sasajima Y, Kato T, Ikeda S, Ishikawa M, et al. Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix. Gynecol Oncol 2009; 115: 488-92.
3. Estape R, Angioli R, Wagman F, Madrigal M, Janicek M, Ganjei-Azar P, et al. Significance of intraperitoneal cytology in patients undergoing radical hysterectomy. Gynecol Oncol 1998; 68: 169-71.
4. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989; 35: 314-20.
5. Kilgore LC, Orr JW Jr, Hatch KD, Shingleton HM, Roberson J. Peritoneal cytology in patients with squamous cell carcinoma of the cervix. Gynecol Oncol 1984; 19: 24-9.
6. Imachi M, Tsukamoto N, Matsuyama T, Nakano H. Peritoneal cytology in patients with carcinoma of the uterine cervix. Gynecol Oncol 1987; 26: 202-7.
7. Kashimura M, Sugihara K, Toki N, Matsuura Y, Kawagoe T, Kamura T, et al. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 1997; 67: 285-90.
8. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73: 177-83.
9. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989; 35: 314-20.
10. Morris PC, Haugen J, Anderson B, Buller R. The significance of peritoneal cytology in stage IB cervical cancer. Obstet Gynecol 1992; 80: 196-8.